Rapid detection of the main carbapenemases in Brazil directly from spiked blood culture using the RESIST-3 O.K.N. immunoassay
暂无分享,去创建一个
[1] A. Gales,et al. Evaluation of a rapid immunochromatographic test for detection of distinct variants of Klebsiella pneumoniae carbapenemase (KPC) in Enterobacteriaceae. , 2017, Journal of microbiological methods.
[2] A. Gales,et al. Detection of OXA-370 directly from rectal swabs and blood culture vials using an immunochromatographic assay. , 2017, Journal of microbiological methods.
[3] A. Zavascki,et al. Dissemination of blaOXA-370 gene among several Enterobacteriaceae species in Brazil , 2017, European Journal of Clinical Microbiology and Infectious Diseases.
[4] F. Davies,et al. Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[5] A. Gales,et al. Antimicrobial resistance in Enterobacteriaceae in Brazil: focus on β-lactams and polymyxins , 2016, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].
[6] Young Bae Kim,et al. Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods , 2016, Front. Microbiol..
[7] B. Limbago,et al. The Problem of Carbapenemase-Producing-Carbapenem-Resistant-Enterobacteriaceae Detection , 2016, Journal of Clinical Microbiology.
[8] M. Yousefi,et al. Current methods for the identification of carbapenemases , 2016, Journal of chemotherapy.
[9] A. Corso,et al. Triton Hodge Test: Improved Protocol for Modified Hodge Test for Enhanced Detection of NDM and Other Carbapenemase Producers , 2015, Journal of Clinical Microbiology.
[10] M. Asensi,et al. Clonal Dissemination of OXA-370-Producing Klebsiella pneumoniae in Rio de Janeiro, Brazil , 2015, Antimicrobial Agents and Chemotherapy.
[11] Yi-Tsung Lin,et al. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan. , 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[12] S. Pournaras,et al. Evaluation of a New Phenotypic OXA-48 Disk Test for Differentiation of OXA-48 Carbapenemase-Producing Enterobacteriaceae Clinical Isolates , 2015, Journal of Clinical Microbiology.
[13] F. Tuon,et al. Molecular epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae in different facilities in Southern Brazil. , 2015, American Journal of Infection Control.
[14] D. Sarkis,et al. How to detect carbapenemase producers? A literature review of phenotypic and molecular methods. , 2014, Journal of microbiological methods.
[15] L. Lutz,et al. Emergence of NDM-1-producing Enterobacteriaceae in Porto Alegre, Brazil. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[16] H. Giamarellou,et al. Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches , 2014, Expert opinion on pharmacotherapy.
[17] M. G. Dalarosa,et al. Detection of OXA-370, an OXA-48-Related Class D β-Lactamase, in Enterobacter hormaechei from Brazil , 2014, Antimicrobial Agents and Chemotherapy.
[18] G. Daikos,et al. Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions , 2012, Clinical Microbiology Reviews.
[19] P. Nordmann,et al. Carbapenem resistance in Enterobacteriaceae: here is the storm! , 2012, Trends in molecular medicine.
[20] Thierry Naas,et al. Global Spread of Carbapenemase-producing Enterobacteriaceae , 2011, Emerging infectious diseases.
[21] L. Martínez-Martínez,et al. Non-molecular detection of carbapenemases in Enterobacteriaceae clinical isolates. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[22] Rafael Cantón,et al. EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance , 2012 .